Michio Kato

Fucosylated haptoglobin is a novel marker for pancreatic cancer: A detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation

Noriko Okuyama, Yoshihito Ide, Miyako Nakano et al. · International Journal of Cancer · 2005 · 292 citations

Life Sciences, Biochemistry, Oncology +17

Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: A multicenter randomized controlled trial

Akinori Kasahara, Norio Hayashi, Naoki Hiramatsu et al. · Hepatology · 1995 · 161 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +13

Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma

Yasuhito Tanaka, Motokazu Mukaide, Etsuro Orito et al. · Journal of Hepatology · 2006 · 132 citations

Medicine, Genetics, Molecular Genetics +16

Declining Incidence of Hepatocellular Carcinoma in Osaka, Japan, from 1990 to 2003

Hideo Tanaka, Yasuharu Imai, Naoki Hiramatsu et al. · Annals of Internal Medicine · 2008 · 128 citations

Medicine, Infectious Diseases, Oncology +17

Post-treatment Levels of α-Fetoprotein Predict Incidence of Hepatocellular Carcinoma After Interferon Therapy

Tsugiko Oze, Naoki Hiramatsu, Takayuki Yakushijin et al. · Clinical Gastroenterology and Hepatology · 2013 · 107 citations · Full text

Medicine, Oncology, Pathology +11